NPPA warns pharmaceutical companies for ceiling prices of coronary stents

National Pharmaceutical Pricing Authority (NPPA) on Monday warned the companies manufacturing and marketing coronary stents and hospitals to comply with the notified ceiling price of stents and to adhere the pricing norms, said Ministry of Chemicals & Fertilizers.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More